Sai Parenteral’s IPO Date, Price Band per share, Allotment Details
Sai Parenteral’s IPO is set to open for subscription from March 24 to March 27, 2026, with the company aiming to raise around ₹409 crores through a book-built issue. The IPO price band is fixed at ₹372 to ₹392 per share, making it a mid-sized offering in the pharma IPO segment. Investors can expect the IPO allotment on March 30, 2026, while the shares are scheduled to be listed on BSE and NSE on April 2, 2026. Backed by steady financial growth and expansion plans, this IPO is gaining traction among investors tracking upcoming IPOs in India, pharma sector IPOs, and mainboard IPO listings in 2026.
The minimum investment in Sai Parenteral’s IPO is ₹14,896 for 1 lot (38 shares). Retail investors can apply for up to 13 lots, which amounts to ₹1,93,648.
Sai Parenteral’s IPO Overview
| Particulars | Details |
|---|---|
| IPO Open Date | March 24, 2026 |
| IPO Close Date | March 27, 2026 |
| Allotment Date | March 30, 2026 |
| Listing Date | April 2, 2026 |
| Face Value | ₹5 per share |
| Price Band | ₹372 to ₹392 per share |
| Issue Size | ₹409 Crores (Approx) |
| Fresh Issue | ₹285 Crores |
| Offer for Sale | 35,00,000 Shares |
| Issue Type | Book Built Issue |
| Listing Exchange | BSE, NSE |
Sai Parenteral’s IPO Allotment Details
The allotment for Sai Parenteral’s IPO is expected to be finalized on March 30, 2026. Investors can check their IPO allotment status online through the registrar website or stock exchange portals after finalization.
- Refund initiation: April 1, 2026
- Shares credit to Demat: April 1, 2026
Minimum Investment & Lot Size
The IPO has a fixed lot size, making it accessible for retail investors with a moderate investment amount.
- Minimum investment: ₹14,896
- Maximum retail investment: ₹1,93,648
Sai Parenteral’s IPO Market Lot
| Category | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 38 | ₹14,896 |
| Retail Maximum | 13 | 494 | ₹1,93,648 |
| S-HNI Minimum | 14 | 532 | ₹2,08,544 |
| S-HNI Maximum | 67 | 2,546 | ₹9,98,032 |
| B-HNI Minimum | 68 | 2,584 | ₹10,12,928 |
Also Read: Powerica IPO Open/Close Date, Price Band, GMP
IPO Reservation Structure
| Investor Category | Allocation |
|---|---|
| QIB | 50% |
| NII (HNI) | 15% |
| Retail Investors | 35% |
Company Overview
Sai Parenteral’s Ltd., established in 2001, is a pharmaceutical company engaged in manufacturing and marketing a wide range of formulations. The company serves both domestic and international markets and operates across therapeutic segments such as cardiovascular, anti-diabetic, antibiotics, and dermatology.
Sai Parenteral’s IPO Listing Date
Sai Parenteral’s shares are scheduled to list on April 2, 2026 on both BSE and NSE. The listing performance will depend on market sentiment, subscription demand, and grey market trends closer to the listing date.
How to Apply for Sai Parenteral’s IPO
Investors can apply for this IPO using multiple methods:
- Login to your net banking account with ASBA facility
- Select IPO section and choose Sai Parenteral’s IPO
- Enter lot size and bid price (or cut-off price)
- Confirm application and block funds
Alternatively:
- Apply via UPI through stock brokers
- Use trading apps like Zerodha, Upstox, etc.
- Submit offline IPO forms via brokers
FAQ
The price band is ₹372 to ₹392 per share.
Investors need to apply for a minimum of 38 shares.
The IPO opens on March 24, 2026 and closes on March 27, 2026.
The allotment is expected on March 30, 2026.
Disclaimer: This article is for educational and informational purposes only and should not be considered investment advice. Investors should conduct their own research and read and understand all official company documents, including the DRHP/RHP, with the assistance of a legally registered and certified financial professional before making any investment decisions. Any opinions or reviews expressed in this article are for informational purposes only and do not constitute a recommendation to buy or sell securities.
